115 related articles for article (PubMed ID: 38806072)
1. Gpbar-1/cAMP/PKA signaling mitigates macrophage-mediated acute cholestatic liver injury via antagonizing NLRP3-ASC inflammasome.
Zhuang L; Jia N; Zhang L; Zhang Q; Antwi SO; Sartorius K; Wu K; Sun D; Xi D; Lu Y
Biochim Biophys Acta Mol Basis Dis; 2024 Aug; 1870(6):167266. PubMed ID: 38806072
[TBL] [Abstract][Full Text] [Related]
2. Chenodeoxycholic acid activates NLRP3 inflammasome and contributes to cholestatic liver fibrosis.
Gong Z; Zhou J; Zhao S; Tian C; Wang P; Xu C; Chen Y; Cai W; Wu J
Oncotarget; 2016 Dec; 7(51):83951-83963. PubMed ID: 27924062
[TBL] [Abstract][Full Text] [Related]
3. NOX4 promotes Kupffer cell inflammatory response via ROS-NLRP3 to aggravate liver inflammatory injury in acute liver injury.
Zhai L; Pei H; Yang Y; Zhu Y; Ruan S
Aging (Albany NY); 2022 Jul; 14(17):6905-6916. PubMed ID: 35832027
[TBL] [Abstract][Full Text] [Related]
4. NLRP3 inflammasome priming and activation in cholestatic liver injury via the sphingosine 1-phosphate/S1P receptor 2/Gα
Hou L; Zhang Z; Yang L; Chang N; Zhao X; Zhou X; Yang L; Li L
J Mol Med (Berl); 2021 Feb; 99(2):273-288. PubMed ID: 33388881
[TBL] [Abstract][Full Text] [Related]
5. Bile Acids Control Inflammation and Metabolic Disorder through Inhibition of NLRP3 Inflammasome.
Guo C; Xie S; Chi Z; Zhang J; Liu Y; Zhang L; Zheng M; Zhang X; Xia D; Ke Y; Lu L; Wang D
Immunity; 2016 Oct; 45(4):802-816. PubMed ID: 27692610
[TBL] [Abstract][Full Text] [Related]
6. Hyperglycemia aggravates acute liver injury by promoting liver-resident macrophage NLRP3 inflammasome activation via the inhibition of AMPK/mTOR-mediated autophagy induction.
Wang Q; Wei S; Zhou S; Qiu J; Shi C; Liu R; Zhou H; Lu L
Immunol Cell Biol; 2020 Jan; 98(1):54-66. PubMed ID: 31625631
[TBL] [Abstract][Full Text] [Related]
7. Bidirectional Role of NLRP3 During Acute and Chronic Cholestatic Liver Injury.
Frissen M; Liao L; Schneider KM; Djudjaj S; Haybaeck J; Wree A; Rolle-Kampczyk U; von Bergen M; Latz E; Boor P; Trautwein C
Hepatology; 2021 May; 73(5):1836-1854. PubMed ID: 32748971
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of NLRP3 inflammasome by thioredoxin-interacting protein in mouse Kupffer cells as a regulatory mechanism for non-alcoholic fatty liver disease development.
He K; Zhu X; Liu Y; Miao C; Wang T; Li P; Zhao L; Chen Y; Gong J; Cai C; Li J; Li S; Ruan XZ; Gong J
Oncotarget; 2017 Jun; 8(23):37657-37672. PubMed ID: 28499273
[TBL] [Abstract][Full Text] [Related]
9. Celastrol ameliorates Propionibacterium acnes/LPS-induced liver damage and MSU-induced gouty arthritis via inhibiting K63 deubiquitination of NLRP3.
Yan CY; Ouyang SH; Wang X; Wu YP; Sun WY; Duan WJ; Liang L; Luo X; Kurihara H; Li YF; He RR
Phytomedicine; 2021 Jan; 80():153398. PubMed ID: 33130474
[TBL] [Abstract][Full Text] [Related]
10. Prim-O-glucosycimifugin attenuates liver injury in septic mice by inhibiting NLRP3 inflammasome/caspase-1 signaling cascades in macrophages.
Liu LL; Yan X; Xue KY; Wang XM; Li LY; Chen HY; Li RL; Li H; Lan J; Xin JJ; Li X; Zhuo CL; Wu Z; Zhang D; Huang WJ; Wang YL; Li XY; Jiang W; Zhang HY
Phytomedicine; 2022 Nov; 106():154427. PubMed ID: 36088791
[TBL] [Abstract][Full Text] [Related]
11. Bone marrow stromal cells attenuate LPS-induced mouse acute liver injury via the prostaglandin E 2-dependent repression of the NLRP3 inflammasome in Kupffer cells.
Miao CM; Jiang XW; He K; Li PZ; Liu ZJ; Cao D; Ou ZB; Gong JP; Liu CA; Cheng Y
Immunol Lett; 2016 Nov; 179():102-113. PubMed ID: 27666012
[TBL] [Abstract][Full Text] [Related]
12. Cathepsin B inhibition ameliorates the non-alcoholic steatohepatitis through suppressing caspase-1 activation.
Tang Y; Cao G; Min X; Wang T; Sun S; Du X; Zhang W
J Physiol Biochem; 2018 Nov; 74(4):503-510. PubMed ID: 30019185
[TBL] [Abstract][Full Text] [Related]
13. A new mechanism of obeticholic acid on NASH treatment by inhibiting NLRP3 inflammasome activation in macrophage.
Huang S; Wu Y; Zhao Z; Wu B; Sun K; Wang H; Qin L; Bai F; Leng Y; Tang W
Metabolism; 2021 Jul; 120():154797. PubMed ID: 33984334
[TBL] [Abstract][Full Text] [Related]
14. Geraniol ameliorates acute liver failure induced by lipopolysaccharide/D-galactosamine via regulating macrophage polarization and NLRP3 inflammasome activation by PPAR-γ methylation Geraniol alleviates acute liver failure.
Ma J; Xu Y; Zhang M; Li Y
Biochem Pharmacol; 2023 Apr; 210():115467. PubMed ID: 36849063
[TBL] [Abstract][Full Text] [Related]
15. Antcin A alleviates pyroptosis and inflammatory response in Kupffercells of non-alcoholic fatty liver disease by targeting NLRP3.
Ruan S; Han C; Sheng Y; Wang J; Zhou X; Guan Q; Li W; Zhang C; Yang Y
Int Immunopharmacol; 2021 Nov; 100():108126. PubMed ID: 34492534
[TBL] [Abstract][Full Text] [Related]
16. INT-777 attenuates NLRP3-ASC inflammasome-mediated neuroinflammation via TGR5/cAMP/PKA signaling pathway after subarachnoid hemorrhage in rats.
Hu X; Yan J; Huang L; Araujo C; Peng J; Gao L; Liu S; Tang J; Zuo G; Zhang JH
Brain Behav Immun; 2021 Jan; 91():587-600. PubMed ID: 32961266
[TBL] [Abstract][Full Text] [Related]
17. High Glucose-Aggravated Hepatic Insulin Resistance: Role of the NLRP3 Inflammasome in Kupffer Cells.
Zheng T; Wang Q; Dong Y; Ma W; Zhang Y; Zhao Y; Bian F; Chen L
Obesity (Silver Spring); 2020 Jul; 28(7):1270-1282. PubMed ID: 32538511
[TBL] [Abstract][Full Text] [Related]
18. TGR5 Regulates Macrophage Inflammation in Nonalcoholic Steatohepatitis by Modulating NLRP3 Inflammasome Activation.
Shi Y; Su W; Zhang L; Shi C; Zhou J; Wang P; Wang H; Shi X; Wei S; Wang Q; Auwerx J; Schoonjans K; Yu Y; Pan R; Zhou H; Lu L
Front Immunol; 2020; 11():609060. PubMed ID: 33692776
[TBL] [Abstract][Full Text] [Related]
19. Macrophage Sphingosine 1-Phosphate Receptor 2 Blockade Attenuates Liver Inflammation and Fibrogenesis Triggered by NLRP3 Inflammasome.
Hou L; Yang L; Chang N; Zhao X; Zhou X; Dong C; Liu F; Yang L; Li L
Front Immunol; 2020; 11():1149. PubMed ID: 32695095
[TBL] [Abstract][Full Text] [Related]
20. Fatty acid activates NLRP3 inflammasomes in mouse Kupffer cells through mitochondrial DNA release.
Pan J; Ou Z; Cai C; Li P; Gong J; Ruan XZ; He K
Cell Immunol; 2018 Oct; 332():111-120. PubMed ID: 30103942
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
